Active clearance of human amyloid β 1-42 peptide aggregates from the rat ventricular system

Neuropathology

Volumn 24, Issue 3, 2004, Pages 194-200

  Nakagawa, Yasushi ^a,b   Yuzuriha, Takefumi ^b   Iwaki, Toru ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Hizen National Mental Hospital   (Japan)

Author keywords

amyloid peptide; Aggregate; Alzheimer's disease; Rat; Short term infusion

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; SYNTHETIC PEPTIDE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CHOROID PLEXUS; EXPERIMENTAL MODEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFUSION; LATERAL BRAIN VENTRICLE; MALE; MENINGEAL ARTERY; MONONUCLEAR CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; RAT; RAT STRAIN; TISSUE FIXATION;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANIMALS; CEREBRAL VENTRICLES; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; METABOLIC CLEARANCE RATE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 4644292823     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2004.00549.x     Document Type: Article

References (30)

1. Roher AE, Lowenson JD, Clarke S et al. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 1993; 268: 3072-3083.
2. Jarrett JT, Berger EP, Lansbury PT Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993; 32: 4693-4697.
3. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 1991; 563: 311-314.
4. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 1993; 13: 1676-1687.
5. Seubert P, Vigo-Pelfrey C, Esch F et al. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 1992; 359: 325-327.
6. Ogomori K, Kitamoto T, Tateishi J, Sato Y, Suetsugu M, Abe M. Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. Am J Pathol 1989; 134: 243-251.
7. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 1987; 57: 230-236.
8. Iwaki T, Wisniewski T, Iwaki A et al. Accumulation of alpha B-crystallin in central nervous system glia and neurons in pathologic conditions. Am J Pathol 1992; 140: 345-356.
9. Pluta R, Barcikowska M, Januszewski S, Misicka A, Lipkowski AW. Evidence of blood-brain barrier permeability/leakage for circulating human Alzheimer's β-amyloid(1-42)-peptide. Neuroreport 1996; 7: 1261-1265.
10. Clemens JA, Stephenson DT. Implants containing beta-amyloid protein are not neurotoxic to young and old rat brain. Neurobiol Aging 1992; 13: 581-586.
11. Emre M, Geula C, Ransil BJ, Mesulam MM. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain. Neurobiol Aging 1992; 13: 553-559.
12. Games D, Khan KM, Soriano FG et al. Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain. Neurobiol Aging 1992; 13: 569-576.
13. Frautschy SA, Baird A, Cole GM. Effects of injected Alzheimer beta-amyloid cores in rat brain. Proc Natl Acad Sci USA 1991; 88: 8362-8366.
14. Frautschy SA, Cole GM, Baird A. Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid. Am J Pathol 1992; 140: 1389-1399.
15. Frautschy SA, Yang F, Calderon L, Cole GM. Rodent models of Alzheimer's disease: rat A beta infusion approaches to amyloid deposits. Neurobiol Aging 1996; 17: 311-321.
16. Kowall NW, Beal MF, Busciglio J, Duffy LK, Yankner BA. An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. Proc Natl Acad Sci USA 1991; 88: 7247-7251.
17. Kowall NW, McKee AC, Yankner BA, Beal MF. In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment. Neurobiol Aging 1992; 13: 537-542.
18. Nitta A, Itoh A, Hasegawa T, Nabeshima T. beta-Amyloid protein-induced Alzheimer's disease animal model. Neurosci Lett 1994; 170: 63-66. Erratum in: Neurosci Lett 1994; 172: 180.
19. Nitta A, Itoh A, Hasegawa T, Nabeshima T. beta-Amyloid protein-induced Alzheimer's disease animal model. Neurosci Lett 1994; 170: 63-66. Erratum in: Neurosci Lett 1994; 172: 180.
20. Rush DK, Aschmies S, Merriman MC. Intracerebral beta-amyloid(25-35) produces tissue damage: is it neurotoxic? Neurobiol Aging 1992; 13: 591-594.
21. Snow AD, Sekiguchi RT, Nochlin D, Kalaria RN, Kimata K. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am J Pathol 1994; 144: 337-347.
22. Stein-Behrens B, Adams K, Yeh M, Sapolsky R. Failure of beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat. Neurobiol Aging 1992; 13: 577-579.
23. Waite J, Cole GM, Frautschy SA, Connor DJ, Thal LJ. Solvent effects on beta protein toxicity in vivo. Neurobiol Aging 1992; 13: 595-599.
24. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 1989; 24: 173-182.
25. Ohgami T, Kitamoto T, Shin RW, Kaneko Y, Ogomori K, Tateishi J. Increased SP without microglia in Alzheimer's disease. Acta Neuropathol (Berl) 1991; 81: 242-247.
26. Frackowiak J, Wisniewski HM, Wegiel J et al. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils. Acta Neuropathol (Berl) 1992; 84: 225-233.
27. Davis JB, McMurray HF, Schubert D. The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochem Biophys Res Commun 1992; 189: 1096-1100.
28. Shaffer LM, Dority MD, Gupta-Bansal R, Frederickson RC, Younkin SG, Brunden KR. Amyloid beta protein (A beta) removal by neuroglial cells in culture. Neurobiol Aging 1995; 16: 737-745.
29. Schenk D, Barbour R, Dunn W et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173-177.
30. Iwata N, Tsubuki S, Takaki Y et al. Identification of the major Aβ 1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 2000; 6: 143-150.